The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Uterine Cavity Form Intra-Uterine Devices Market Research Report 2024

Global Uterine Cavity Form Intra-Uterine Devices Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1737435

No of Pages : 108

Synopsis
An intrauterine device (IUD) is a contraceptive device inserted into the uterus to prevent pregnancy. It is a T-shaped device made of plastic and contains copper or hormones. The device is inserted into the uterus by medical professionals to play a role by preventing the fertilization of eggs or the implantation of zygote. The working principle of copper intrauterine devices is to release copper ions, which are toxic to sperm and hinder fertilization. Hormone type intrauterine devices work by releasing progesterone, thickening cervical mucus and preventing sperm from entering the egg. The design of a uterine intrauterine device conforms to the shape of the uterus and helps to reduce the risk of expulsion or displacement. This is a long-term contraceptive method that can prevent pregnancy within a few years, depending on the type of device used. Although intrauterine device (IUD) is a very effective contraceptive method, it is not suitable for everyone. Women with certain diseases, such as pelvic inflammatory disease or uterine abnormalities, may not be able to use intrauterine devices. It is important to consult medical professionals to determine whether an intrauterine device is the right contraceptive choice for you. Overall, intrauterine devices (IUDs) are a safe and effective contraceptive choice that can provide long-term contraceptive protection. Its high efficiency and low maintenance requirements make it a popular choice for many women.
Global Uterine Cavity Form Intra-Uterine Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Uterine Cavity Form Intra-Uterine Devices market research.
Key manufacturers engaged in the Uterine Cavity Form Intra-Uterine Devices industry include Bayer AG, Merck & Co., Inc., Pfizer Inc., Allergan, Teva Pharmaceutical Industries Ltd., CooperSurgical, Medicines360, Agile Therapeutics and Ferring Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Uterine Cavity Form Intra-Uterine Devices were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Uterine Cavity Form Intra-Uterine Devices market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Uterine Cavity Form Intra-Uterine Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bayer AG
Merck & Co., Inc.
Pfizer Inc.
Allergan
Teva Pharmaceutical Industries Ltd.
CooperSurgical
Medicines360
Agile Therapeutics
Ferring Pharmaceuticals
Gedeon Richter
HLL Lifecare Limited
Lupin Pharmaceuticals, Inc.
Okamoto Industries, Inc.
Pregna International Ltd.
Synapse Medical Sdn Bhd
Segment by Type
Copper IUD
Silver Plated IUD
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Uterine Cavity Form Intra-Uterine Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Uterine Cavity Form Intra-Uterine Devices Market Overview
1.1 Product Overview and Scope of Uterine Cavity Form Intra-Uterine Devices
1.2 Uterine Cavity Form Intra-Uterine Devices Segment by Type
1.2.1 Global Uterine Cavity Form Intra-Uterine Devices Market Value Comparison by Type (2023-2029)
1.2.2 Copper IUD
1.2.3 Silver Plated IUD
1.3 Uterine Cavity Form Intra-Uterine Devices Segment by Application
1.3.1 Global Uterine Cavity Form Intra-Uterine Devices Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Uterine Cavity Form Intra-Uterine Devices Market Size Estimates and Forecasts
1.4.1 Global Uterine Cavity Form Intra-Uterine Devices Revenue 2018-2029
1.4.2 Global Uterine Cavity Form Intra-Uterine Devices Sales 2018-2029
1.4.3 Global Uterine Cavity Form Intra-Uterine Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Uterine Cavity Form Intra-Uterine Devices Market Competition by Manufacturers
2.1 Global Uterine Cavity Form Intra-Uterine Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Uterine Cavity Form Intra-Uterine Devices Average Price by Manufacturers (2018-2023)
2.4 Global Uterine Cavity Form Intra-Uterine Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Uterine Cavity Form Intra-Uterine Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Uterine Cavity Form Intra-Uterine Devices, Product Type & Application
2.7 Uterine Cavity Form Intra-Uterine Devices Market Competitive Situation and Trends
2.7.1 Uterine Cavity Form Intra-Uterine Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Uterine Cavity Form Intra-Uterine Devices Players Market Share by Revenue
2.7.3 Global Uterine Cavity Form Intra-Uterine Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Uterine Cavity Form Intra-Uterine Devices Retrospective Market Scenario by Region
3.1 Global Uterine Cavity Form Intra-Uterine Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Uterine Cavity Form Intra-Uterine Devices Global Uterine Cavity Form Intra-Uterine Devices Sales by Region: 2018-2029
3.2.1 Global Uterine Cavity Form Intra-Uterine Devices Sales by Region: 2018-2023
3.2.2 Global Uterine Cavity Form Intra-Uterine Devices Sales by Region: 2024-2029
3.3 Global Uterine Cavity Form Intra-Uterine Devices Global Uterine Cavity Form Intra-Uterine Devices Revenue by Region: 2018-2029
3.3.1 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Region: 2018-2023
3.3.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Region: 2024-2029
3.4 North America Uterine Cavity Form Intra-Uterine Devices Market Facts & Figures by Country
3.4.1 North America Uterine Cavity Form Intra-Uterine Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Uterine Cavity Form Intra-Uterine Devices Sales by Country (2018-2029)
3.4.3 North America Uterine Cavity Form Intra-Uterine Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Uterine Cavity Form Intra-Uterine Devices Market Facts & Figures by Country
3.5.1 Europe Uterine Cavity Form Intra-Uterine Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Uterine Cavity Form Intra-Uterine Devices Sales by Country (2018-2029)
3.5.3 Europe Uterine Cavity Form Intra-Uterine Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Uterine Cavity Form Intra-Uterine Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Uterine Cavity Form Intra-Uterine Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Uterine Cavity Form Intra-Uterine Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Uterine Cavity Form Intra-Uterine Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Uterine Cavity Form Intra-Uterine Devices Market Facts & Figures by Country
3.7.1 Latin America Uterine Cavity Form Intra-Uterine Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Uterine Cavity Form Intra-Uterine Devices Sales by Country (2018-2029)
3.7.3 Latin America Uterine Cavity Form Intra-Uterine Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Uterine Cavity Form Intra-Uterine Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Uterine Cavity Form Intra-Uterine Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Uterine Cavity Form Intra-Uterine Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Uterine Cavity Form Intra-Uterine Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Uterine Cavity Form Intra-Uterine Devices Sales by Type (2018-2029)
4.1.1 Global Uterine Cavity Form Intra-Uterine Devices Sales by Type (2018-2023)
4.1.2 Global Uterine Cavity Form Intra-Uterine Devices Sales by Type (2024-2029)
4.1.3 Global Uterine Cavity Form Intra-Uterine Devices Sales Market Share by Type (2018-2029)
4.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Type (2018-2029)
4.2.1 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Type (2018-2023)
4.2.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Type (2024-2029)
4.2.3 Global Uterine Cavity Form Intra-Uterine Devices Revenue Market Share by Type (2018-2029)
4.3 Global Uterine Cavity Form Intra-Uterine Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Uterine Cavity Form Intra-Uterine Devices Sales by Application (2018-2029)
5.1.1 Global Uterine Cavity Form Intra-Uterine Devices Sales by Application (2018-2023)
5.1.2 Global Uterine Cavity Form Intra-Uterine Devices Sales by Application (2024-2029)
5.1.3 Global Uterine Cavity Form Intra-Uterine Devices Sales Market Share by Application (2018-2029)
5.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Application (2018-2029)
5.2.1 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Application (2018-2023)
5.2.2 Global Uterine Cavity Form Intra-Uterine Devices Revenue by Application (2024-2029)
5.2.3 Global Uterine Cavity Form Intra-Uterine Devices Revenue Market Share by Application (2018-2029)
5.3 Global Uterine Cavity Form Intra-Uterine Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer AG Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Corporation Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck & Co., Inc. Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Inc. Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Allergan Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Teva Pharmaceutical Industries Ltd.
6.5.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Ltd. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Pharmaceutical Industries Ltd. Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 CooperSurgical
6.6.1 CooperSurgical Corporation Information
6.6.2 CooperSurgical Description and Business Overview
6.6.3 CooperSurgical Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CooperSurgical Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.6.5 CooperSurgical Recent Developments/Updates
6.7 Medicines360
6.6.1 Medicines360 Corporation Information
6.6.2 Medicines360 Description and Business Overview
6.6.3 Medicines360 Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medicines360 Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.7.5 Medicines360 Recent Developments/Updates
6.8 Agile Therapeutics
6.8.1 Agile Therapeutics Corporation Information
6.8.2 Agile Therapeutics Description and Business Overview
6.8.3 Agile Therapeutics Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Agile Therapeutics Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.8.5 Agile Therapeutics Recent Developments/Updates
6.9 Ferring Pharmaceuticals
6.9.1 Ferring Pharmaceuticals Corporation Information
6.9.2 Ferring Pharmaceuticals Description and Business Overview
6.9.3 Ferring Pharmaceuticals Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ferring Pharmaceuticals Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.9.5 Ferring Pharmaceuticals Recent Developments/Updates
6.10 Gedeon Richter
6.10.1 Gedeon Richter Corporation Information
6.10.2 Gedeon Richter Description and Business Overview
6.10.3 Gedeon Richter Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Gedeon Richter Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.10.5 Gedeon Richter Recent Developments/Updates
6.11 HLL Lifecare Limited
6.11.1 HLL Lifecare Limited Corporation Information
6.11.2 HLL Lifecare Limited Uterine Cavity Form Intra-Uterine Devices Description and Business Overview
6.11.3 HLL Lifecare Limited Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.11.4 HLL Lifecare Limited Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.11.5 HLL Lifecare Limited Recent Developments/Updates
6.12 Lupin Pharmaceuticals, Inc.
6.12.1 Lupin Pharmaceuticals, Inc. Corporation Information
6.12.2 Lupin Pharmaceuticals, Inc. Uterine Cavity Form Intra-Uterine Devices Description and Business Overview
6.12.3 Lupin Pharmaceuticals, Inc. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lupin Pharmaceuticals, Inc. Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.12.5 Lupin Pharmaceuticals, Inc. Recent Developments/Updates
6.13 Okamoto Industries, Inc.
6.13.1 Okamoto Industries, Inc. Corporation Information
6.13.2 Okamoto Industries, Inc. Uterine Cavity Form Intra-Uterine Devices Description and Business Overview
6.13.3 Okamoto Industries, Inc. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Okamoto Industries, Inc. Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.13.5 Okamoto Industries, Inc. Recent Developments/Updates
6.14 Pregna International Ltd.
6.14.1 Pregna International Ltd. Corporation Information
6.14.2 Pregna International Ltd. Uterine Cavity Form Intra-Uterine Devices Description and Business Overview
6.14.3 Pregna International Ltd. Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Pregna International Ltd. Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.14.5 Pregna International Ltd. Recent Developments/Updates
6.15 Synapse Medical Sdn Bhd
6.15.1 Synapse Medical Sdn Bhd Corporation Information
6.15.2 Synapse Medical Sdn Bhd Uterine Cavity Form Intra-Uterine Devices Description and Business Overview
6.15.3 Synapse Medical Sdn Bhd Uterine Cavity Form Intra-Uterine Devices Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Synapse Medical Sdn Bhd Uterine Cavity Form Intra-Uterine Devices Product Portfolio
6.15.5 Synapse Medical Sdn Bhd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Uterine Cavity Form Intra-Uterine Devices Industry Chain Analysis
7.2 Uterine Cavity Form Intra-Uterine Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Uterine Cavity Form Intra-Uterine Devices Production Mode & Process
7.4 Uterine Cavity Form Intra-Uterine Devices Sales and Marketing
7.4.1 Uterine Cavity Form Intra-Uterine Devices Sales Channels
7.4.2 Uterine Cavity Form Intra-Uterine Devices Distributors
7.5 Uterine Cavity Form Intra-Uterine Devices Customers
8 Uterine Cavity Form Intra-Uterine Devices Market Dynamics
8.1 Uterine Cavity Form Intra-Uterine Devices Industry Trends
8.2 Uterine Cavity Form Intra-Uterine Devices Market Drivers
8.3 Uterine Cavity Form Intra-Uterine Devices Market Challenges
8.4 Uterine Cavity Form Intra-Uterine Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’